Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis

Alzheimer's disease (AD) and Parkinson's disease (PD) are two major neurodegenerative diseases worldwide. Demographic aging is in rapid progress in China. Up-to-date estimates of AD and PD prevalence have not been provided. Studies that reported the prevalence of AD and PD in China were id...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in aging neuroscience Vol. 12; p. 603854
Main Authors Cui, Lei, Hou, Na-Na, Wu, Hong-Mei, Zuo, Xiang, Lian, Yi-Zhi, Zhang, Chao-Nan, Wang, Zhen-Feng, Zhang, Xiong, Zhu, Jian-Hong
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 21.12.2020
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease (AD) and Parkinson's disease (PD) are two major neurodegenerative diseases worldwide. Demographic aging is in rapid progress in China. Up-to-date estimates of AD and PD prevalence have not been provided. Studies that reported the prevalence of AD and PD in China were identified via a systematic database search from 1985 to 2018. Meta-analysis, local polynomial regression and autoregressive integrated moving average model were used for analyses. A total of 99 studies were included in the study with populations of 385,312 and 227,228, respectively for AD and PD. The overall prevalence of AD and PD following age standardization was 3.20% [95% confidence interval (CI) = 3.17-3.23] and 1.06% (95% CI = 1.02-1.10), respectively in individuals over 60 years old. The rates increased drastically for every 10-years increment of age. The yearly prevalence of AD was predicted to increase from 3.81 to 6.17% in the next 5 years. Significant differences were observed between genders [male to female odds ratio (OR) for AD = 0.57, 95% CI = 0.51-0.64; OR for PD = 1.25, 95% CI = 1.06-1.46], and between education levels (Illiterate to non-illiterate OR for AD = 2.99, 95% CI = 2.38-3.75), but not between urban and rural settings. Our results provide an updated insight into the epidemiology of AD and PD in China and their associated rates and ratios. The findings may facilitate China policy makers and health professionals mitigate the related health issues.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work
Reviewed by: Bo Su, Shandong University, China; Xueqiu Jian, The University of Texas Health Science Center at San Antonio, United States
Edited by: Taher Darreh-Shori, Karolinska Institutet (KI), Sweden
ISSN:1663-4365
1663-4365
DOI:10.3389/fnagi.2020.603854